San Diego, CA · Founded 2019 · Privately Held (backing)
Operator of a biotechnology company intended to discover innovative therapeutics for the treatment of cancers that are resistant to current therapies. 858 Therapeutics is based in San Diego, CA and was founded in 2019. Its last known valuation is $140 million. It has raised $110 million across 3 recorded rounds; the latest was a $25.2 million early-stage round in Jun 2024.
Last price · $/share
—
Implied valuation
$140.0M
Total raised
$110.0M
Last round
Early Stage VC
Jun 2024
Team — not yet on record
No current team members for 858 Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of 858 Therapeutics with a free account
·Watch 858 Therapeutics: the Monday email on marks, rounds and moves
